Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
University of Miami School of Medicine
mi
from
Miami, FL
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
University of Miami School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
University of South Florida
mi
from
Tampa, FL
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Augusta University
mi
from
Augusta, GA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Indiana University
mi
from
Indianapolis, IN
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
University of Iowa College of Medicine
mi
from
Iowa City, IA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
University of Iowa College of Medicine
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
University of Maryland Medical Center
mi
from
Baltimore, MD
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Massachusetts General Hospital
mi
from
Boston, MA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Lahey Clinic
mi
from
Burlington, MA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Lahey Clinic
mi
from
Burlington, MA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Las Vegas Clinic
mi
from
Las Vegas, NV
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Las Vegas Clinic
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Buffalo General Hospital
mi
from
Buffalo, NY
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Buffalo General Hospital
mi
from
Buffalo, NY
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Hospital For Special Surgery/New York Presbyterian Hospital Cornell Campus
mi
from
New York, NY
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Hospital For Special Surgery/New York Presbyterian Hospital Cornell Campus
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Carolinas HealthCare System
mi
from
Charlotte, NC
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Carolinas HealthCare System
mi
from
Charlotte, NC
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Duke University Health System
mi
from
Durham, NC
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Duke University Health System
mi
from
Durham, NC
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Oregon Health and Science University
mi
from
Portland, OR
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Rhode Island Hospital
mi
from
Providence, RI
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Wesley Neurology Clinic
mi
from
Cordova, TN
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Wesley Neurology Clinic
mi
from
Cordova, TN
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Vanderbilt Medical Center
mi
from
Nashville, TN
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Vanderbilt Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
UT Southwestern
mi
from
Dallas, TX
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
UT Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Methodist Neurological Institute
mi
from
Houston, TX
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Methodist Neurological Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
University of Vermont Medical Center
mi
from
Burlington, VT
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
University of Vermont Medical Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Univ of Washington
mi
from
Seattle, WA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
University of Alabama
mi
from
Birmingham, AL
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
California Pacific Medical Center
mi
from
San Francisco, CA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Medical Associates of North Georgia
mi
from
Canton, GA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Medical Associates of North Georgia
mi
from
Canton, GA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Wayne State University School of Medicine
mi
from
Detroit, MI
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Wayne State University School of Medicine
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Mount Sinai School of Medicine
mi
from
New York, NY
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Ohio State University Medical Center
mi
from
Columbus, OH
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
Hospital Italiano
mi
from
Ciudad Autonoma,
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Hospital Italiano
mi
from
Ciudad Autonoma,
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Barrow Neurological Institute
mi
from
Phoenix, AZ
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Barrow Neurological Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Stanford University
mi
from
Stanford, CA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver
mi
from
Aurora, CO
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Shepherd Center
mi
from
Atlanta, GA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Shepherd Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Johns Hopkins
mi
from
Baltimore, MD
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Beth Israel Deaconess
mi
from
Boston, MA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Beth Israel Deaconess
mi
from
Boston, MA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Univ of Massachusetts Med School
mi
from
Worcester, MA
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Univ of Massachusetts Med School
mi
from
Worcester, MA
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Multiple Sclerosis Research Center of New York
mi
from
New York, NY
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Multiple Sclerosis Research Center of New York
mi
from
New York, NY
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
Ohio State University
mi
from
Columbus, OH
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated:  1/13/2018
UT Southwestern Medical Center
mi
from
Dallas, TX
Biobank For MS And Other Demyelinating Diseases
Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
Status: Enrolling
Updated: 1/13/2018
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis: An Observational Case-control Study
Status: Enrolling
Updated:  1/13/2018
Department of Health and Exercise Science
mi
from
Fort Collins, CO
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis
Medical Marijuana and Its Effects on Motor Function in People With Multiple Sclerosis: An Observational Case-control Study
Status: Enrolling
Updated: 1/13/2018
Department of Health and Exercise Science
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Cross-over Study of Nelotanserin Versus Placebo in Lewy Body Dementia (LBD) Subjects Experiencing Visual Hallucinations (VH)
Status: Enrolling
Updated:  1/16/2018
US123
mi
from
Fountain Valley, CA
Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Cross-over Study of Nelotanserin Versus Placebo in Lewy Body Dementia (LBD) Subjects Experiencing Visual Hallucinations (VH)
Status: Enrolling
Updated: 1/16/2018
US123
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Cross-over Study of Nelotanserin Versus Placebo in Lewy Body Dementia (LBD) Subjects Experiencing Visual Hallucinations (VH)
Status: Enrolling
Updated:  1/16/2018
US129
mi
from
Lincoln, NE
Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Cross-over Study of Nelotanserin Versus Placebo in Lewy Body Dementia (LBD) Subjects Experiencing Visual Hallucinations (VH)
Status: Enrolling
Updated: 1/16/2018
US129
mi
from
Lincoln, NE
Click here to add this to my saved trials
Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Cross-over Study of Nelotanserin Versus Placebo in Lewy Body Dementia (LBD) Subjects Experiencing Visual Hallucinations (VH)
Status: Enrolling
Updated:  1/16/2018
US114
mi
from
Boca Raton, FL
Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia
A Phase 2, Double-blind, Randomized, Placebo-controlled Cross-over Study of Nelotanserin Versus Placebo in Lewy Body Dementia (LBD) Subjects Experiencing Visual Hallucinations (VH)
Status: Enrolling
Updated: 1/16/2018
US114
mi
from
Boca Raton, FL
Click here to add this to my saved trials